(5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one(CAS: 168828-90-8)

Regulatory guidelines for (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one (CAS: 168828-90-8) include GHS classification, REACH regulations, and FDA/EPA requirements. The compound must comply with hazardous material transport regulations, and specific handling and storage guidelines are necessary to ensure safety in the workplace.

In synthesis, alternatives to (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one (CAS: 168828-90-8) include analogs such as (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(piperidin-4-yl)phenyl]-1,3-oxazolidin-2-one and isomers with different substituents. Common alternative reagents include other oxazolidinones and morpholine derivatives.

The market and research trends for (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one (CAS: 168828-90-8) show increasing interest in its potential as an antibiotic and immunomodulatory agent. The compound is being explored in clinical trials and research for its therapeutic properties, with a focus on developing more effective and less toxic treatments.

Waste containing (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one (CAS: 168828-90-8) should be collected in appropriate containers and labeled as hazardous. Proper incineration or professional waste disposal services should be utilized to ensure environmental safety. Precautions include wearing personal protective equipment and adhering to local environmental protection regulations.